We’ll show you what’s new with us here, offer you interesting media outlets that relate to our work, and you can find our press releases here.
Notes from a trip to “The most startup friendly country in the world”
Jun 13, 2022
At the end of April, Karel Kubias (one of the partners of i&i Biotech Fund) and Jiří Moos (CEO of i&i Prague) attended an event in Riga, Latvia, called Roche Latvia Innovations Day. Here you can read their blog where they describe their impressions from the event and, more importantly, provide further evidence that the Baltic States can serve as inspiration for the Czech Republic.
Jaromír Zahrádka On SEznam zprávy agenda podcast
Apr 13, 2022
Check out the new episode of the Agenda podcast on Seznam Zprávy. Jaromír Zahrádka, CEO of i&i Bio, talked about our investments this year, investing in Life Sciences and how to find a champion. The video is in Czech language.
i&i Biotech fund Invests $1.5 Million in Sampling Human to Support the Development of Engineered Cells for Single Cell Analysis
Apr 12, 2022
This year's third i&i Bio investment goes to Sampling Human, an early stage, Life Sciences technology company that has developed a diagnostic platform that harnesses genetically engineered cells to analyze other cells in their environment.
i&i Bio's investment of $2 million goes to Dracen Pharmaceuticals, company developing cancer-fighting drugs
Mar 7, 2022
i&i Bio has announced investment of USD 2 million in Dracen Pharmaceuticals. This company is completing the first phase of clinical testing of DRP-104 (sirpiglenastat), which has the potential to significantly help the treatment of cancer.
i&i Biotech Fund invests €1 million in Celeris Therapeutics, company using AI to develop drugs
Feb 24, 2022
i&i Bio has announced an investment of EUR 1 million in CelerisTx, an early-stage drug discovery company using artificial intelligence to predict biomolecular interactions and generate new chemical entities. CelerisTx exploits its proprietary platform to develop new drugs in oncology and neurology.
Jaromír Zahrádka On the Life Science Get2Gether podcast
Dec 12, 2021
In mid-December, Christian Soschner invited our CEO Jaromír Zahrádka to his podcast, which he regularly broadcasts on Life Science Get2Gether (LS G2G).